Disease Info Card

Hyperprolactinemia

Information about Hyperprolactinemia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hyperprolactinemia

Most recent studies have shown that Hyperprolactinemia shares some biological mechanisms with acromegaly, adenoma, amenorrhea, anovulation, diabetes-mellitus, endocrine-system-diseases, erectile-dysfunction, female-infertility, galactorrhea-associated-with-childbirth, hypogonadism, hypopituitarism, hypothyroidism, infertility, neoplasms, pituitary-adenoma, pituitary-diseases, pituitary-neoplasms, polycystic-ovary-syndrome, prolactinoma, schizophrenia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hyperprolactinemia, and have been seen in publications frequently: Aging, Cell Proliferation, Circadian Rhythm, Excretion, Fertilization, Gonadotropin Secretion, Growth Hormone Secretion, Hormone Secretion, Immune Response, Lactation, Localization, Luteinizing Hormone Secretion, Menarche, Menopause, Menstruation, Ovulation, Pathogenesis, Prolactin Secretion, Secretion, Spermatogenesis

Quite a number of genes have been found to play important roles in Hyperprolactinemia, such as BRD2, DBT, FUT2, GGH, GH1, GHRH, GNRH1, IGF1, INS, PBX1, PLOD1, POMC, PRL, SHBG, SQLE, SST, TH, TRH, VIP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.